Latest Articles
- Clinical/Scientific NotesAsymptomatic CNS demyelination related to TNF-α inhibitor therapyFarwa Ali, Ruple S. LaughlinOctober 28, 2016
- Clinical/Scientific NotesParoxysmal sneezing in NMOSD: Further evidence of the localization of the human sneeze centerA. Sebastian López-Chiriboga, Josephine F. Huang, Eoin P. Flanagan, et al.October 28, 2016
- Clinical/Scientific NotesA comparison of tissue-based and recombinant protein–based assays for detecting PCA-Tr/DNER-IgGNora Alfugham, Matthew Roforth, Lars Komorowski, et al.October 28, 2016
- ArticleRisk of relapse after natalizumab withdrawalResults from the French TYSEDMUS cohortCaroline Papeix, Sandra Vukusic, Romain Casey, et al.October 28, 2016
- ArticleIncreased prevalence of autoimmune disease within C9 and FTD/MND cohortsCompleting the pictureZachary A. Miller, Virginia E. Sturm, Gamze Balci Camsari, et al.October 28, 2016
- ArticleInsufficient treatment of severe depression in neuromyelitis optica spectrum disorderVelina S. Chavarro, Maureen A. Mealy, Alexandra Simpson, et al.October 24, 2016
- ArticleNatalizumab treatment leads to an increase in circulating CXCR3-expressing B cellsMaija Saraste, Tarja-Leena Penttilä, Laura AirasOctober 24, 2016
- Clinical/Scientific NotesIntracranial multifocal Rosai-Dorfman diseaseHan Chen, Haiyan Zhou, Zhi SongOctober 24, 2016
- ArticleAlemtuzumab treatment alters circulating innate immune cells in multiple sclerosisCatharina C. Gross, Diana Ahmetspahic, Tobias Ruck, et al.October 12, 2016
- ArticleInduction of gut regulatory CD39+ T cells by teriflunomide protects against EAEJavier Ochoa-Repáraz, Sara L. Colpitts, Christopher Kircher, et al.October 12, 2016
Pages
Advertisement
Dr. Sevil Yaşar and Dr. Behnam Sabayan